These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

489 related articles for article (PubMed ID: 10637135)

  • 1. Catechol metabolites of polychlorinated biphenyls inhibit the catechol-O-methyltransferase-mediated metabolism of catechol estrogens.
    Garner CE; Burka LT; Etheridge AE; Matthews HB
    Toxicol Appl Pharmacol; 2000 Jan; 162(2):115-23. PubMed ID: 10637135
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phenolphthalein metabolite inhibits catechol-O-methyltransferase-mediated metabolism of catechol estrogens: a possible mechanism for carcinogenicity.
    Garner CE; Matthews HB; Burka LT
    Toxicol Appl Pharmacol; 2000 Jan; 162(2):124-31. PubMed ID: 10637136
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 17 beta-estradiol metabolism by hamster hepatic microsomes: comparison of catechol estrogen O-methylation with catechol estrogen oxidation and glutathione conjugation.
    Butterworth M; Lau SS; Monks TJ
    Chem Res Toxicol; 1996 Jun; 9(4):793-9. PubMed ID: 8831825
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Strong inhibitory effects of common tea catechins and bioflavonoids on the O-methylation of catechol estrogens catalyzed by human liver cytosolic catechol-O-methyltransferase.
    Nagai M; Conney AH; Zhu BT
    Drug Metab Dispos; 2004 May; 32(5):497-504. PubMed ID: 15100171
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of catechol-O-methyltransferase inhibition on estrogen metabolite and oxidative DNA damage levels in estradiol-treated MCF-7 cells.
    Lavigne JA; Goodman JE; Fonong T; Odwin S; He P; Roberts DW; Yager JD
    Cancer Res; 2001 Oct; 61(20):7488-94. PubMed ID: 11606384
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microsomal hydroxylation of 2- and 4-fluoroestradiol to catechol metabolites and their conversion to methyl ethers: catechol estrogens as possible mediators of hormonal carcinogenesis.
    Ashburn SP; Han X; Liehr JG
    Mol Pharmacol; 1993 Apr; 43(4):534-41. PubMed ID: 8386306
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 17 beta-Estradiol metabolism by hamster hepatic microsomes. Implications for the catechol-O-methyl transferase-mediated detoxication of catechol estrogens.
    Butterworth M; Lau SS; Monks TJ
    Drug Metab Dispos; 1996 May; 24(5):588-94. PubMed ID: 8723741
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro model of mammary estrogen metabolism: structural and kinetic differences between catechol estrogens 2- and 4-hydroxyestradiol.
    Dawling S; Hachey DL; Roodi N; Parl FF
    Chem Res Toxicol; 2004 Sep; 17(9):1258-64. PubMed ID: 15377160
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estrogenic phenol and catechol metabolites of PCBs modulate catechol-O-methyltransferase expression via the estrogen receptor: potential contribution to cancer risk.
    Ho PW; Garner CE; Ho JW; Leung KC; Chu AC; Kwok KH; Kung MH; Burka LT; Ramsden DB; Ho SL
    Curr Drug Metab; 2008 May; 9(4):304-9. PubMed ID: 18473748
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Catechol estrogen 4-hydroxyequilenin is a substrate and an inhibitor of catechol-O-methyltransferase.
    Yao J; Li Y; Chang M; Wu H; Yang X; Goodman JE; Liu X; Liu H; Mesecar AD; Van Breemen RB; Yager JD; Bolton JL
    Chem Res Toxicol; 2003 May; 16(5):668-75. PubMed ID: 12755597
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phytochemicals inhibit catechol-O-methyltransferase activity in cytosolic fractions from healthy human mammary tissues: implications for catechol estrogen-induced DNA damage.
    van Duursen MB; Sanderson JT; de Jong PC; Kraaij M; van den Berg M
    Toxicol Sci; 2004 Oct; 81(2):316-24. PubMed ID: 15254334
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Catechol-O-methyltransferase (COMT)-mediated metabolism of catechol estrogens: comparison of wild-type and variant COMT isoforms.
    Dawling S; Roodi N; Mernaugh RL; Wang X; Parl FF
    Cancer Res; 2001 Sep; 61(18):6716-22. PubMed ID: 11559542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro estrogenicity of the catechol metabolites of selected polychlorinated biphenyls.
    Garner CE; Jefferson WN; Burka LT; Matthews HB; Newbold RR
    Toxicol Appl Pharmacol; 1999 Jan; 154(2):188-97. PubMed ID: 9925803
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparisons of brain, uterus, and liver mRNA expression for cytochrome p450s, DNA methyltransferase-1, and catechol-o-methyltransferase in prepubertal female Sprague-Dawley rats exposed to a mixture of aryl hydrocarbon receptor agonists.
    Desaulniers D; Xiao GH; Leingartner K; Chu I; Musicki B; Tsang BK
    Toxicol Sci; 2005 Jul; 86(1):175-84. PubMed ID: 15858227
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The carcinogenic activity of ethinyl estrogens is determined by both their hormonal characteristics and their conversion to catechol metabolites.
    Zhu BT; Roy D; Liehr JG
    Endocrinology; 1993 Feb; 132(2):577-83. PubMed ID: 8381068
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Soy isoflavones decrease the catechol-O-methyltransferase-mediated inactivation of 4-hydroxyestradiol in cultured MCF-7 cells.
    Lehmann L; Jiang L; Wagner J
    Carcinogenesis; 2008 Feb; 29(2):363-70. PubMed ID: 18192686
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative study of ortho- and meta-nitrated inhibitors of catechol-O-methyltransferase: interactions with the active site and regioselectivity of O-methylation.
    Palma PN; Rodrigues ML; Archer M; Bonifácio MJ; Loureiro AI; Learmonth DA; Carrondo MA; Soares-da-Silva P
    Mol Pharmacol; 2006 Jul; 70(1):143-53. PubMed ID: 16618795
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Equine catechol estrogen 4-hydroxyequilenin is a more potent inhibitor of the variant form of catechol-O-methyltransferase.
    Li Y; Yao J; Chang M; Nikolic D; Yu L; Yager JD; Mesecar AD; van Breemen RB; Bolton JL
    Chem Res Toxicol; 2004 Apr; 17(4):512-20. PubMed ID: 15089093
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Benzotropolone inhibitors of estradiol methylation: kinetics and in silico modeling studies.
    Lambert JD; Chen D; Wang CY; Ai N; Sang S; Ho CT; Welsh WJ; Yang CS
    Bioorg Med Chem; 2005 Apr; 13(7):2501-7. PubMed ID: 15755652
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of the catechol-O-methyltransferase-catalyzed O-methylation of 2- and 4-hydroxyestradiol by catecholamine: implications for the mechanism of estrogen-induced carcinogenesis.
    Zhu BT; Liehr JG
    Arch Biochem Biophys; 1993 Jul; 304(1):248-56. PubMed ID: 8323288
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.